SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-09
👔
Immunome Inc.
@IMNM_InsiderForm 4 Filing: BIENAIME JEAN JACQUES Sells $408,080 of $IMNM
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Immunome Inc.
Ticker: $IMNM
Transaction Value
$408,080
Price/Share: $19.43
transaction date
2026-06-05
Shares: 21,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BIENAIME JEAN JACQUES, holds the title of Director at Immunome Inc..
On 2026-06-05, the insider transacted 21,000 shares.The shares were transacted at a weighted average price of $19.43 per share, resulting in a total market-relevant value of $408,080.
Executive Summary Summary
BIENAIME JEAN JACQUES (Director) sold $408K of $IMNM
Post-Transaction Position: 32,915 shares
SEC Accession No: 0001221590-26-000015 (CIK: 1221590)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.